To investigate this, we analyzed 27 formalin-fixed paraffin-embedded (FFPE) samples from ovarian and breast cancer patients, all of whom had BRCA1 loss-of-heterozygosity (LOH). The gene discussed is BRCA1; the disease is breast carcinoma.